Disclosure of Payments
In everything we do, we always start by asking ourselves "How can we create more value for people living with severe diseases?"
To do this, we work in partnership with various stakeholders including healthcare professionals, healthcare organisations and patient organisations. We are committed to operating at the highest ethical standards and therefore ensure we are transparent with these engagements and associated transfers of value.
We disclose all of this information in line with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.
Disclosure of payments to patient organisations in Europe
As part of our commitment to treating patients with major diseases, UCB supports a variety of programmes for those affected and their families. These include websites, information materials, events or special patient programmes, all with the goal of improving the quality of life of our patients beyond medication.
Please visit our global website for information on the patient groups, or companies that UCB has supported.
IE-DA-2400174 | December 2024
Transfers of value to heathcare professionals and healthcare organisations
We publish details of the transfers of value we make to healthcare professionals, healthcare organisations and other stakeholders annually.
Our transfer of value data and the methodological notes are published on the ABPI's Disclosure UK platform. This can be accessed below.
UK tax strategy
As per HMRC regulations, we are pleased to publish our UK tax strategy